Association of glutathione S-transferase, EPHX, and p53 codon 72 gene polymorphisms with adult acute myeloid leukemia

DNA and Cell Biology

Volumn 30, Issue 1, 2011, Pages 39-46

  Chauhan, Pradeep Singh ^a   Ihsan, Rakhshan ^a   Yadav, Dhirendra Singh ^a   Mishra, Ashwani Kumar ^a   Bhushan, Bharat ^a   Soni, Abha ^a   Kaushal, Mishi ^a   Devi, Thoudam Regina ^a   Saluja, Sumita ^a   Gupta, Dipendra Kumar ^a   Mittal, Vishakha ^a   Saxena, Sunita ^a   Kapur, Sujala ^a  

^a SAFDARJUNG HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE M1; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CODON; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CODON; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; XENOBIOTICS; YOUNG ADULT;

EID: 78651414264     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1092     Document Type: Article

References (48)

1. Ali-Osman, F., Akande, O., Antoun, G., Mao, J.X., and Buo-lamwini, J. (1997). Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272, 10004-10012.
2. Anantharaman, D., Chaubal, P.M., Kannan, S., Bhisey, R.A., and Mahimkar, M.B. (2007). Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28, 1455-1462.
3. Arruda, V.R., Lima, C.S., Grignoli, C.R., de Mel, M.B., Lorand-Metze, I., Alberto, F.L., Saad, S.T., and Costa, F.F. (2001). Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur J Haematol 66, 383-388.
4. Aydin-Sayitoglu, M., Hatirnaz, O., Erensoy, N., and Ozbek, U. (2006). Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol 81, 162-170.
5. Bajpai, P., Tripathi, A.K., and Agrawal, D. (2007). Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk Res 31, 1359-1363.
6. Benhamou, S., Reinikainen, M., Bouchardy, C., Dayer, P., and Hirvonen, A. (1998). Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 58, 5291-5293.
7. Bhushan, B., Chauhan, P.S., Saluja, S., Verma, S., Mishra, A.K., Siddiqui, S., and Kapur, S. (2010). Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome. Clin Exp Med 10, 33-40.
8. Brøgger, J., Steen, V.M., Eiken, H.G., Gulsvik, A., and Bakke, P. (2006). Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J 27, 682-688.
9. Chauhan, P.S., Bhushan, B., Mishra, A.K., Singh, L.C., Saluja, S., Verma, S., Gupta, D.K., Mittal, V., Chaudhry, S., and Kapur, S. (2010). Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and im-munophenotypic features. Med Oncol March 31 [Epub ahead of print].
10. Chen, C.L., Liu, Q., and Relling, M.V. (1996). Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 6, 187-191.
11. Crump, C., Chen, C., Appelbaum, F.R., Kopecky, K.J., Schwartz, S.M., Willman, C.L., Slovak, M.L., and Weiss, N.S. (2000). Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev 9, 457-460.
12. Damin, A.P., Frazzon, A.P., Damin, D.C., Roehe, A., Hermes, V., Zettler, C., and Alexandre, C.O. (2006). Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Cancer Detect Prev 30, 523-529.
13. Das, P., Shaik, A.P., and Bammidi, V.K. (2009). Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia. Leuk Lymphoma 50, 1345-1351.
14. Dong, H., Bonala, R.R., Suzuki, N., Johnson, F., Grollman, A.P., and Shibutani, S. (2004). Mutagenic potential of benzo[a]pyrene-derived DNA adducts positioned in codon 273 of the human P53 gene. Biochemistry 43, 15922-15928.
15. Ellis, N.A., Huo, D., Yildiz, O., Worrillow, L.J., Banerjee, M., Le Beau, M.M., Larson, R.A., Allan, J.M., and Onel, K. (2008). MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood 112, 741-749.
16. Garća-Closas, M., Kelsey, K.T., Hankinson, S.E., Spiegelman, D., Springer, K., Willett, W.C., Speizer, F.E., and Hunter, D.J. (1999). Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility. J Natl Cancer Inst 91, 1960-1964.
17. Garte, S., Taioli, E., Popov, T., Kalina, I., Sram, R., and Farmer, P. (2007). Role of GSTT1 deletion in DNA oxidative damage by exposure to polycyclic aromatic hydrocarbons in humans. Int J Cancer 120, 2499-2503.
18. Groves, F.D., Linet, M.S., and Devesa, S.S. (1994). Epidemiology of human leukemia. Curr Opin Hematol 1, 321-326.
19. Gsur, A., Zidek, T., Schnattinger, K., Feik, E., Haidinger, G., Hollaus, P., Mohn-Staudner, A., Armbruster, C., Ma-dersbacher, S., Schatzl, G., Trieb, K., Vutuc, C., and Micksche, M. (2003). Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer 89, 702-706.
20. Honma, H.N., De Capitani, E.M., Perroud, M.W., Jr., Barbeiro, A.S., Toro, I.F., Costa, D.B., Lima, C.S., and Zambon, L. (2008). Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer 61, 152-162.
21. Huang, W.Y., Chatterjee, N., Chanock, S., Dean, M., Yeager, M., Schoen, R.E., Hou, L.F., Berndt, S.I., Yadavalli, S., Johnson, C.C., and Hayes, R.B. (2005). Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 14, 152-157. (Pubitemid 40165296)
22. Ignaszak-Szczepaniak, M., Horst-Sikorska, W., Sawicka, J., Kaczmarek, M., and Slomski, R. (2006). The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients. Oncol Rep 16, 65-71.
23. Infante-Rivard, C., Labuda, D., Krajinovic, M., and Sinnett, D. (1999). Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology 10, 481-487.
24. Jain, M., Kumar, S., Rastogi, N., Lal, P., Ghoshal, U.C., Tiwari, A., Pant, M.C., Baiq, M.Q., and Mittal, B. (2006). GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esopha-geal cancer patients from North India. Cancer Lett 242, 60-67.
25. Jain, M., Tilak, A.R., Upadhyay, R., Kumar, A., and Mittal, B. (2008). Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharmacol 230, 247-251.
26. Joseph, T., Kusumakumary, P., Chacko, P., Abraham, A., and Radhakrishna Pillai, M. (2004). Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr Blood Cancer 43, 560-567.
27. Kim, W.J., Kim, H., Kim, C.H., Lee, M.S., Oh, B.R., Lee, H.M., and Katoh, T. (2002). GSTT1-null genotype is a protective factor against bladder cancer. Urology 60, 913-918.
28. Lebailly, P., Willett, E.V., Moorman, A.V., Roman, E., Cart-wright, R., Morgan, G.J., and Wild, C.P. (2002). Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities. Br J Haematol 116, 587-594.
29. Lee, K.M., Ward, M.H., Han, S., Ahn, H.S., Kang, H.J., Choi, H.S., Shin, H.Y., Koo, H.H., Seo, J.J., Choi, J.E., Ahn, Y.O., and Kang, D. (2009). Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res 33, 250-258.
30. Maekawa, K., Itoda, M., Hanioka, N., Saito, Y., Murayama, N., Nakajima, O., Soyama, A., Ishida, S., Ozawa, S., Ando, M., and Sawada, J. (2003). Non-synonymous single nucleotide alterations in the microsomal epoxide hydrolase gene and their functional effects. Xenobiotica 33, 277-287.
31. Majumdar, S., Mondal, B.C., Ghosh, M., Dey, S., Mukho-padhyay, A., Chandra, S., and Dasgupta, U.B. (2008). Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Eur J Cancer Prev 17, 125-132.
32. Miyata, M., Kudo, G., Lee, Y.H., Yang, T.J., Gelboin, H.V., Fer-nandez-Salguero, P., Kimura, S., and Gonzalez. F.J. (1999). Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a] anthracene. J Biol Chem 274, 23963-23968.
33. Mondal, B.C., Paria, N., Majumdar, S., Chandra, S., Mukho-padhyay, A., Chaudhuri, U., and Dasgupta, U.B. (2005). Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia. Eur J Cancer Prev 14, 281-284.
34. Naoe, T., Takeyama, K., Yokozawa, T., Kiyoi, H., Seto, M., Uike, N., Ino, T., Utsunomiya, A., Maruta, A., Jin-nai, I., Kamada, N., Kubota, Y., Nakamura, H., Shimazaki, C., Horiike, S., Kodera, Y., Saito, H., Ueda, R., Wiemels, J., and Ohno, R. (2000). Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 6, 4091-4095.
35. Pandey, S.N., Jain, M., Nigam, P., Choudhuri, G., and Mittal, B. (2006). Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India. Biomarkers 11, 250-261.
36. Ryberg, D., Skaug, V., Hewer, A., Phillips, D.H., Harries, L.W., Wolf, C.R., Ogreid, D., Ulvik, A., Vu, P., and Haugen, A. (2002). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18, 1285-1289.
37. Seidegard, J., Vorachek, W.R., Pero, R.W., and Pearson, W.R. (1988). Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 85, 7293-7297.
38. Shimada, T., Yamazaki, H., Oda, Y., Hiratsuka, A., Watabe, T., and Guengerich, F.P. (1996). Activation and inactivation of carcinogenic dihaloalkanes and other compounds by gluta-thione S-transferase 5-5 in Salmonella typhimurium tester strain NM5004. Chem Res Toxicol 9, 333-340.
39. Silveira Vda, S., Canalle, R., Scrideli, C.A., Queiroz, R.G., and Tone, L.G. (2009). Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children. Environ Mol Mutagen 51, 48-56.
40. Smith, C.A., and Harrison, D.J. (1997). Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350, 630-633.
41. Takeuchi, S., Matsushita, M., Tsukasaki, K., Takeuchi, N., To-monaga, M., Komatsu, N., Ikezoe, T., Uehara, Y., and Koeffler, H.P. (2005). P53 codon 72 polymorphism is associated with disease progression in adult T-cell leukaemia/lymphoma. Br J Haematol 131, 552-553.
42. Taningher, M., Malacarne, D., Izzotti, A., Ugolini, D., and Par-odi, S. (1999). Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res 436, 227-261.
43. To-Figueras, J., Gené, M., Gómez-Catalán, J., Piqué, E., Borrego, N., Caballero, M., Cruellas, F., Raya, A., Dicenta, M., and Corbella, J. (2002). Microsomal epoxide hydrolase and gluta-thione S-transferase polymorphisms in relation to laryngeal carcinoma risk. Cancer Lett 187, 95-101.
44. To-Figueras, J., Gené, M., Gómez-Catalán, J., Piqué, E., Borrego, N., and Corbella, J. (2001). Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. Cancer Lett 173, 155-162.
45. Voho, A., Metsola, K., Anttila, S., Impivaara, O., Järvisalo, J., Vainio, H., Husgafvel-Pursiainen, K., and Hirvonen, A. (2006). EPHX1 gene polymorphisms and individual susceptibility to lung cancer. Cancer Lett 237, 102-108.
46. Wang, Y.C., Lee, H.S., Chen, S.K., Chang, Y.Y., and Chen, C.Y. (1999). Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 35, 226-230.
47. Xiong, X., Wang, M., Wang, L., Liu, J., Zhao, X., Tian, Z., and Wang, J. (2009). Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia. Leuk Res 33, 1454-1458.
48. Zhao, M., Lewis, R., Gustafson, D.R., Wen, W.Q., Cerhan, J.R., and Zheng, W. (2001). No apparent association of GSTP1 A(313)G polymorphism with breast cancer risk among post-menopausal Iowa women. Cancer Epidemiol Biomarkers Prev 10, 1301-1302.